Identification of a large intra-exonic deletion in BRCA2 exon 18 in a pancreatic ductal adenocarcinoma

By 2030, pancreatic cancer will become the second leading cause of cancer-related deaths in the United States and in Europe. The management of patients with advanced pancreatic cancer relies on chemotherapy and poly (ADP-ribose) polymerase inhibitors for patients who carry BRCA1/2 inactivating alter...

Descripción completa

Detalles Bibliográficos
Autores principales: Debbabi, Inès, Vacher, Sophie, Neuzillet, Cindy, Cros, Jérome, Revillon, Françoise, Petitalot, Ambre, Turpin, Anthony, Antonio, Samantha, Girard, Elodie, Dupain, Célia, Kamal, Maud, Hammel, Pascal, Bièche, Ivan, Masliah-Planchon, Julien, Caputo, Sandrine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869184/
https://www.ncbi.nlm.nih.gov/pubmed/36700131
http://dx.doi.org/10.1177/17588359221146132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869184/
https://www.ncbi.nlm.nih.gov/pubmed/36700131
http://dx.doi.org/10.1177/17588359221146132

Ejemplares similares